
Faculty, Staff and Student Publications
Publication Date
4-1-2024
Journal
Leukemia
Abstract
Resistance to apoptosis in acute myeloid leukemia (AML) cells causes refractory or relapsed disease, associated with dismal clinical outcomes. Ferroptosis, a mode of non-apoptotic cell death triggered by iron-dependent lipid peroxidation, has been investigated as potential therapeutic modality against therapy-resistant cancers, but our knowledge of its role in AML is limited. We investigated ferroptosis in AML cells and identified its mitochondrial regulation as a therapeutic vulnerability. GPX4 knockdown induced ferroptosis in AML cells, accompanied with characteristic mitochondrial lipid peroxidation, exerting anti-AML effects in vitro and in vivo. Electron transport chains (ETC) are primary sources of coenzyme Q
Keywords
Humans, Ferroptosis, Mitochondria, Lipids, Leukemia, Myeloid, Acute, Peptide Hydrolases
DOI
10.1038/s41375-023-02117-2
PMID
38148395
PMCID
PMC11082873
PubMedCentral® Posted Date
May 2024
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Oncology Commons
Comments
This article has been corrected. See Leukemia. 2024 March 08; : .